Liver Resection Is Justified in Patients with BCLC Intermediate Stage Hepatocellular Carcinoma without Microvascular Invasion
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Liver Resection Is Justified in Patients with BCLC Intermediate Stage Hepatocellular Carcinoma without Microvascular Invasion
Authors
Keywords
-
Journal
JOURNAL OF GASTROINTESTINAL SURGERY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-11-26
DOI
10.1007/s11605-019-04251-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The prognostic value of microvascular invasion in early-intermediate stage hepatocelluar carcinoma: a propensity score matching analysis
- (2018) Junyi Shen et al. BMC CANCER
- Cancer statistics, 2018
- (2018) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Preoperative histogram analysis of intravoxel incoherent motion (IVIM) for predicting microvascular invasion in patients with single hepatocellular carcinoma
- (2018) Hongxiang Li et al. EUROPEAN JOURNAL OF RADIOLOGY
- Hepatic resection compared to chemoembolization in intermediate- to advanced-stage hepatocellular carcinoma: A meta-analysis of high-quality studies
- (2018) Myung Han Hyun et al. HEPATOLOGY
- EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
- (2018) Peter R. Galle et al. JOURNAL OF HEPATOLOGY
- Hepatocellular carcinoma
- (2018) Alejandro Forner et al. LANCET
- Surgical resection versus transarterial chemoembolization for BCLC intermediate stage hepatocellular carcinoma: a systematic review and meta-analysis
- (2018) Lei Liang et al. HPB
- Role of liver resection in treating intermediate and advanced stage adolescent and young adult hepatocellular carcinoma patients: A propensity-matching cohort study
- (2018) Wei Zhang et al. International Journal of Surgery
- Long-term survival after partial hepatectomy for sub-stage patients with intermediate stage hepatocellular carcinoma
- (2018) Wen-xin Wei et al. International Journal of Surgery
- Surgical resection improves long-term survival of patients with hepatocellular carcinoma across different Barcelona Clinic Liver Cancer stages
- (2018) Hui Guo et al. Cancer Management and Research
- Liver resection versus transarterial chemoembolization for the initial treatment of Barcelona Clinic Liver Cancer stage B hepatocellular carcinoma
- (2018) Biao Yang et al. Hepatology International
- Microvascular invasion predicts a poor prognosis of solitary hepatocellular carcinoma up to 2 cm based on propensity score matching analysis
- (2018) Han Wang et al. HEPATOLOGY RESEARCH
- AASLD guidelines for the treatment of hepatocellular carcinoma
- (2017) Julie K. Heimbach et al. HEPATOLOGY
- A pre-operative clinical model to predict microvascular invasion and long-term outcome after resection of hepatocellular cancer: The Australian experience
- (2016) S.M. Schlichtemeier et al. EJSO
- Subclassification of patients with intermediate-stage (Barcelona Clinic Liver Cancer stage-B) hepatocellular carcinoma using the up-to-seven criteria and serum tumor markers
- (2016) Haruki Kimura et al. Hepatology International
- Proposed New Sub-Grouping for Intermediate-Stage Hepatocellular Carcinoma Using Albumin-Bilirubin Grade
- (2016) Atsushi Hiraoka et al. ONCOLOGY
- Selection criteria for hepatic resection in intermediate-stage (BCLC stage B) multiple hepatocellular carcinoma
- (2016) Hiroshi Wada et al. SURGERY
- Practice guidelines for the pathological diagnosis of primary liver cancer: 2015 update
- (2016) Wen-Ming Cong et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Nomogram for Preoperative Estimation of Microvascular Invasion Risk in Hepatitis B Virus–Related Hepatocellular Carcinoma Within the Milan Criteria
- (2016) Zhengqing Lei et al. JAMA Surgery
- New insights into molecular diagnostic pathology of primary liver cancer: Advances and challenges
- (2015) Wen-Ming Cong et al. CANCER LETTERS
- Intermediate-stage HCC—upfront resection can be feasible
- (2015) Jian-Hong Zhong et al. Nature Reviews Clinical Oncology
- Intermediate-stage HCC—upfront resection can be feasible
- (2015) Alejandro Forner et al. Nature Reviews Clinical Oncology
- Multiple carcinogenesis contributes to the heterogeneity of HCC
- (2014) Qiang Gao et al. Nature Reviews Gastroenterology & Hepatology
- Recent Advances in the Prevention of Hepatocellular Carcinoma Recurrence
- (2014) Li-Chun Lu et al. SEMINARS IN LIVER DISEASE
- Prognostic factors for hepatocellular carcinoma recurrence
- (2014) Antonio Colecchia WORLD JOURNAL OF GASTROENTEROLOGY
- Determination of Clonal Origin of Recurrent Hepatocellular Carcinoma for Personalized Therapy and Outcomes Evaluation: A New Strategy for Hepatic Surgery
- (2013) Bin Wang et al. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS
- Heterogeneity of Patients with Intermediate (BCLC B) Hepatocellular Carcinoma: Proposal for a Subclassification to Facilitate Treatment Decisions
- (2013) Andrew Burroughs et al. SEMINARS IN LIVER DISEASE
- Molecular classification and clonal differentiation of hepatocellular carcinoma: the step forward for patient selection for liver transplantation
- (2011) Ricardo Gehrau et al. Expert Review of Gastroenterology & Hepatology
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now